It is a small, orally active ghrelin receptor agonist and growth hormone secretagogue, meaning it stimulates the bodys own release of growth hormone and IGF-1 by activating the ghrelin receptor
PMID 39025385
Cognitive protection of sinomenine in type 2 diabetes mellitus through regulating the EGF/Nrf2/HO-1 signaling, the microbiota-gut-brain axis, and hippocampal neuron ferroptosis
To meet the diagnostic criteria for cEDS, a person must meet: Major criterion 1 AND major criterion 2 OR Major criterion 1 AND three or more minor criteria Major Criteria Skin hyperextensibility and atrophic scarring Generalized joint hypermobility Minor Criteria Easy bruising Soft, doughy skin Skin fragility (or traumatic splitting) Molluscoid pseudotumors Subcutaneous spheroids Hernia (or history thereof) Epicanthal folds Complications of joint hypermobility (e.g., sprains, dislocations/subluxations, pain, flexible flatfoot) Family history of a first-degree relative who meets clinical criteria Genetic testing is used to see if a person has a genetic variant that causes vEDS
Benefits of Supplementing with Glutathione Glutathione is one of the few compounds your body actually produces on its own
A GLOW Blend peptide calculator helps estimate syringe units, mL dosing, and peptide concentration after mixing peptides with diluent